Tag: ACS

Vascular Verification Program Verifies First Community Hospital

CHICAGO (January 3, 2025): Intermountain Health St. Mary’s Regional Hospital in Grand Junction Colorado was awarded ACS/SVS Vascular-VP designation on November 19, 2024. By achieving this prestigious status, Intermountain Health St. Mary’s Regional Hospital shows their commitment to delivering high quality treatment for patients receiving vascular surgical and interventional care […]

Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market

SCHAUMBURG, Ill.–(BUSINESS WIRE)–Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Eptifibatide for Injection in the United States as a therapeutic equivalent generic for Integrilin® for Injection (Eptifibatide) approved by the U.S. Food and Drug Administration. Eptifibatide for Injection is indicated for use in […]

Dascena Awarded NIH Grant to Reduce Bias in Acute Coronary Syndrome Diagnosis and Treatment

Latest grant is the 9th awarded to Dascena from the National Institute of Health SAN FRANCISCO–(BUSINESS WIRE)–Dascena, a developer of machine learning diagnostic algorithms to enable early disease intervention and improved care outcomes for patients, has received a grant from the National Institute on Minority Health and Health Disparities (part of the National […]